Copyright
©The Author(s) 2015.
World J Surg Proced. Nov 28, 2015; 5(3): 217-222
Published online Nov 28, 2015. doi: 10.5412/wjsp.v5.i3.217
Published online Nov 28, 2015. doi: 10.5412/wjsp.v5.i3.217
Age (yr) | 57, 8.9 SD |
Status menstrual | |
Premenopausal | 13 (22.8) |
Postmenopausal | 44 (77.2) |
Affected breast | |
Right | 19 (33.3) |
Left | 38 (66.7) |
Tumour location through the breast (quadrant) | |
Upper outer | 16 (28.1) |
Upper inner | 3 (5.3) |
Lower Inner | 3 (5.3) |
Central | 12 (21.1) |
Intersection upper quadrants | 7 (12.3) |
Intersection lower quadrants | 5 (8.8) |
Intersection inner quadrants | 3 (5.3) |
Intersection outer quadrants | 7 (12.3) |
Inframmary fold | 1 (1.8) |
Multifocal | 14 (24.6) |
Radiological tumour size (mm) | 21.7, 12.58 SD |
In situ | 7 (12.3) |
Invasive | 50 (87.7) |
Type of histology | |
Ductal | 39 |
Lobular | 6 |
Mixed | 1 |
Papilar | 1 |
Others | 3 |
Positive estrogenic receptors | 38 |
Positive progesterone receptors | 37 |
Positive Herb2 receptors | 7 |
Ki67 (n = 42) | |
> 10% | 15 |
10%-50% | 19 |
51%-75% | 3 |
> 75% | 4 |
Pathologic tumour size (mm) | 17.1, 9.77 SD |
Patients with lymph nodes positives | 12 (14) |
- Citation: Hernanz F, González-Noriega M, Pérez RV, Gómez-Fleitas M. Versatility of therapeutic reduction mammoplasty in oncoplastic breast conserving surgery. World J Surg Proced 2015; 5(3): 217-222
- URL: https://www.wjgnet.com/2219-2832/full/v5/i3/217.htm
- DOI: https://dx.doi.org/10.5412/wjsp.v5.i3.217